Business Segments Compass Therapeutics, Inc.
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.040 USD | -5.45% |
|
-16.13% | -80.63% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||
Biotechnology (Startups) | - | - | - | 850K | - | |||
Total Assets | 154M | 200M | 157M | 140M | 220M | |||
Interest Expense | -370K | - | - | - | - | |||
Income Tax Expense | - | - | - | - | - | |||
CAPEX | -1.89M | -212K | -30K | -44K | -25K | |||
EBT | -82.18M | -39.22M | -42.49M | -49.38M | -66.49M | |||
D&A | 1.62M | 1.9M | 1.89M | 1.75M | 1.47M | |||
Operating Income | -81.88M | -41.66M | -50.36M | -56.62M | -72.84M | |||
Net Income | -82.18M | -39.22M | -42.49M | -49.38M | -66.49M |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
United States | - | - | - | 850K | - | |||
Total Assets | 154M | 200M | 157M | 140M | 220M | |||
Interest Expense | -370K | - | - | - | - | |||
Income Tax Expense | - | - | - | - | - | |||
D&A | 1.62M | 1.9M | 1.89M | 1.75M | 1.47M | |||
CAPEX | -1.89M | -212K | -30K | -44K | -25K | |||
Net Income | -82.18M | -39.22M | -42.49M | -49.38M | -66.49M | |||
EBT | -82.18M | -39.22M | -42.49M | -49.38M | -66.49M | |||
Operating Income | -81.88M | -41.66M | -50.36M | -56.62M | -72.84M |
- Stock Market
- Stocks
- CMPX Stock
- Financials Compass Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
